The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jul. 24, 2018

Filed:

Dec. 16, 2013
Applicants:

Mara Fornaro, Basel, CH;

David Jonathan Glass, Cambridge, MA (US);

Thomas Jostock, Basel, CH;

Holger Laux, Basel, CH;

Sandrine Romand, Seyssinet-Pariset, FR;

Inventors:

Mara Fornaro, Basel, CH;

David Jonathan Glass, Cambridge, MA (US);

Thomas Jostock, Basel, CH;

Holger Laux, Basel, CH;

Sandrine Romand, Seyssinet-Pariset, FR;

Assignee:

Novartis AG, Basel, CH;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07K 14/65 (2006.01); C12N 15/113 (2010.01); C12P 21/02 (2006.01); C12N 15/11 (2006.01);
U.S. Cl.
CPC ...
C07K 14/65 (2013.01); C12N 15/111 (2013.01); C12N 15/113 (2013.01); C12N 15/1138 (2013.01); C12P 21/02 (2013.01); C12N 2310/14 (2013.01); C12N 2310/531 (2013.01);
Abstract

The invention relates to methods for the production of therapeutic proteins in mammalian cells. In one embodiment, the method comprises producing a therapeutic protein such as IGF-1 in a mammalian cell endogenously expressing a cognate receptor of said recombinant therapeutic protein and wherein binding of said therapeutic protein to said cognate receptor results in a low titer of the therapeutic protein, the method comprising with a mammalian cell being deficient in the expression of the cognate receptor of said therapeutic protein and being transformed with an expression vector comprising a nucleic acid molecule encoding the therapeutic protein: a. Cultivating said cell under conditions allowing the expression of the therapeutic protein; and b. Harvesting the therapeutic protein from the mammalian cell cultivated in step a, wherein said mammalian cell produces at least 1.5 fold more therapeutic protein than a cell in which the expression of the cognate receptor has not been so modified.


Find Patent Forward Citations

Loading…